News Conference News AHA 2017 TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery Shelley Wood November 12, 2017
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Conference News TCT 2017 Early Pilot Study Results Show Symptom Improvement With TMVR Michael O'Riordan November 07, 2017
News Conference News TCT 2017 Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians Ashley Lyles November 06, 2017
News Conference News TCT 2017 MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months TCT Daily Staff November 06, 2017
News Conference News TCT 2017 TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months Yael L. Maxwell November 01, 2017
News Conference News TCT 2017 CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock Todd Neale October 30, 2017
News Daily News Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk Todd Neale October 23, 2017
News Daily News Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI Yael L. Maxwell October 20, 2017
News Daily News Lower Limb Revascularizations Increasing in PAD Patients on Dialysis L.A. McKeown October 18, 2017
News Daily News Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR Shelley Wood October 16, 2017
News Daily News Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR Shelley Wood October 10, 2017
News Daily News High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats Yael L. Maxwell October 06, 2017
News Conference News PCR London Valves 2017 As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging Shelley Wood September 26, 2017
News Daily News Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life Michael O'Riordan September 18, 2017
News Conference News VIVA 2017 EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2017 Caitlin E. Cox August 31, 2017